Jamjoom Pharmaceuticals Factory Co. (4015)
Saudi Exchange (Tadawul) · Health Technology
Screening did not complete: company data missing at the source
Jamjoom Pharmaceuticals Factory Co stock (4015): its screening is incomplete: the source lacks data, per our screen under AAOIFI Shari'ah Standard No. 21 dated 2026-10-29.
Purification shareNot yet computed
We receive the ticker only, with no account and no email.
The screening of Jamjoom Pharmaceuticals Factory Co. is not complete yet. The Sharia results for every stock on Saudi Exchange (Tadawul) are in one free list. Open the free list
Follow this stock on Telegram for free
- Price
- 121.70 SARLast close 2026-10-27
- Market cap
- 8.47 B SARat the 2026-10-27 close
- Symbol
- TADAWUL:4015
- Market
- Saudi Exchange (Tadawul)
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
Identity page only: this company is inside our coverage, but its fundamental figures are incomplete at the source, so it enters no scoring and no ranking.
Figures as of 2026-10-29 13:13
Sharia screening
Screening did not complete: company data missing at the source
We apply AAOIFI Shari'ah Standard No. 21, Financial Paper (Shares and Bonds), issued on 30 Rabi' I 1425 AH (20 May 2004), as published on AAOIFI's website. We last reviewed its limits on 2026-10-01. We read what the standard says; we do not issue fatwas.
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
Jamjoom Pharmaceuticals Factory Co in numbers
Jamjoom Pharmaceuticals Factory Co ranks 2 of 6 in the Health Technology sector on Saudi Exchange (Tadawul) by market cap (8.47 B SAR). Dividends have been paid 3 years running.
Published figures with their date, not financial advice. Market cap and P/E use the 2026-10-27 close.
The five screens, one by one
No score: the screen did not complete
No score: the screen did not complete
We ran 1 of 5 screens; the score did not complete because company data is missing at the source.
| Business activity (sector and industry) | No excluded activity in its sector or industry | Passed |
| Interest-bearing debt to market cap | limit 30% | Not measured: figure missing at the source |
| Cash and interest-bearing securities to market cap | limit 30% | Not measured: figure missing at the source |
| Non-permissible income to revenue | limit 5% | Not measured: figure missing at the source |
| Receivables to market cap | Not run: the standard sets no limit for it |
Purification share
We have not yet measured the share of this company's revenue that comes from non-permissible income, so we show no purification share and do not guess one. We do not publish a per-share amount.
Figures as of 2026-10-29 13:13
Company facts
- Consecutive years paying a dividend 3 years
- Share of profits paid out 60.8%
Figures computed from the company's published financial statements and read on 2026-10-28. They move with every new statement; this states a figure, it is an educational reading, not financial advice.
Fundamental filter
Meets the filter, with stated notes
- The company actually earned a profit over the last twelve months. Met
- Its debt does not exceed twice its shareholders' equity. Not measured
Figures as of 2026-10-28
An automated quality screen on published figures, not financial advice. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
Frequently asked about Jamjoom Pharmaceuticals Factory Co
What is the Sharia safety margin of Jamjoom Pharmaceuticals Factory Co?
For Jamjoom Pharmaceuticals Factory Co, No score: the screen did not complete. The Sharia safety margin, out of 100, measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on the page.
Does Jamjoom Pharmaceuticals Factory Co stock need purification?
We have not yet measured the share of this company's revenue that comes from non-permissible income, so we show no purification share and do not guess one. We do not publish a per-share amount.
Does Jamjoom Pharmaceuticals Factory Co pay dividends?
The company has paid dividends 3 years running, a payout of 60.8% of earnings. Published figures with their date, not a recommendation.
How do I work out zakat on Jamjoom Pharmaceuticals Factory Co shares?
The zakat calculator on this site gives an indicative amount from the value of the shares you hold; detailed rulings belong to scholars.
Which market lists Jamjoom Pharmaceuticals Factory Co?
Jamjoom Pharmaceuticals Factory Co is listed on Saudi Exchange (Tadawul) under the symbol 4015.
Other Health Technology stocks on Saudi Exchange (Tadawul)
No stock by that name in this list.
Figures as of 2026-10-29.
Latest news on the company
- Jamjoom Pharma And Mubadala Bio’s Venture Healthcare Partner To Expand Patient Access To Ustekinumab In UAEReuters ·
- Jamjoom Pharma Q3 Profit SAR 110.21 MillionReuters ·
- Jamjoom Pharma Signs Exclusive Licensing And Commercialization Agreement With Nordic PharmaReuters ·
- Jamjoom Pharma Partners With Idorsia To Advance Insomnia Care For Patients In Saudi And LevantReuters ·
- Jamjoom Pharma Updates On Non-Binding Term Sheet With Pharmaceutical Investment CompanyReuters ·
News from its original sources; the reading is in your account.